There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.

The FDA has extended the review period for the BLA for NT-501 in the treatment of macular telangiectasia type 2.

Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022.

Digital eye strain is more common in patients without presbyopia than in individuals with the refractive condition.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years.

Black and White patients with NAION have a similar pathogenesis, but Black patients with the disease may experience a delayed referral for care, due to its low prevalence in this population. Compared ...

A Prescription Drug User Fee Act date of April 2, 2025 has been assigned to the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...